| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/EURHEARTJ/EHS454 |
| P8608 | Fatcat ID | release_jtu6edd3rfh4hbxrfukmu4mylu |
| P698 | PubMed publication ID | 23355652 |
| P2093 | author name string | Cheuk-Man Yu | |
| David L Hayes | |||
| P2860 | cites work | ??? | Q28267062 |
| Cardiac resynchronization therapy in patients with right bundle branch block: analysis of pooled data from the MIRACLE and Contak CD trials | Q30990838 | ||
| Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association | Q33155461 | ||
| Early and late outcome of treated patients referred for syncope to emergency department: the EGSYS 2 follow-up study | Q33158397 | ||
| Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial | Q34166289 | ||
| Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease | Q34582573 | ||
| Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study | Q35170240 | ||
| High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration | Q35580760 | ||
| Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up | Q36907089 | ||
| Critical appraisal of methods to assess mechanical dyssynchrony | Q37356399 | ||
| Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers | Q37635423 | ||
| Echocardiography, dyssynchrony, and the response to cardiac resynchronization therapy | Q37780030 | ||
| Left ventricular endocardial stimulation for severe heart failure | Q37783392 | ||
| Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial | Q38493735 | ||
| Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). | Q38494075 | ||
| Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial | Q38500965 | ||
| Temporary leadless pacing in heart failure patients with ultrasound-mediated stimulation energy and effects on the acoustic window | Q39981199 | ||
| Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy | Q40034666 | ||
| Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure | Q43489268 | ||
| Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial | Q43507717 | ||
| Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study | Q43892138 | ||
| Significance of QRS morphology in determining the prevalence of mechanical dyssynchrony in heart failure patients eligible for cardiac resynchronization: particular focus on patients with right bundle branch block with and without coexistent left-si | Q44163915 | ||
| A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure | Q45393896 | ||
| Effect of left ventricular lead concordance to the delayed contraction segment on echocardiographic and clinical outcomes after cardiac resynchronization therapy | Q47199137 | ||
| Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. | Q47212005 | ||
| New method for cardiac resynchronization therapy: transapical endocardial lead implantation for left ventricular free wall pacing. | Q47762066 | ||
| Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction | Q47866464 | ||
| Mid-term outcomes of triple-site vs. conventional cardiac resynchronization therapy: a preliminary study | Q47943440 | ||
| Biventricular pacing is superior to right ventricular pacing in bradycardia patients with preserved systolic function: 2-year results of the PACE trial | Q48603437 | ||
| Speckle-tracking radial strain reveals left ventricular dyssynchrony in patients with permanent right ventricular pacing | Q48902531 | ||
| Biventricular pacing in patients with bradycardia and normal ejection fraction | Q48953996 | ||
| Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. | Q50870071 | ||
| Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. | Q51062399 | ||
| Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy. | Q51093286 | ||
| Cardiac-resynchronization therapy for the prevention of heart-failure events. | Q51136225 | ||
| Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the 'Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)' study. | Q51156753 | ||
| Comparison of efficacy of reverse remodeling and clinical improvement for relatively narrow and wide QRS complexes after cardiac resynchronization therapy for heart failure. | Q51617123 | ||
| Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. | Q53511853 | ||
| Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex | Q57298863 | ||
| Effect of Posterolateral Scar Tissue on Clinical and Echocardiographic Improvement After Cardiac Resynchronization Therapy | Q57298888 | ||
| Clinical and echocardiographic predictors of nonresponse to cardiac resynchronization therapy | Q57299443 | ||
| 2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy De | Q57312501 | ||
| Triple-Site Versus Standard Cardiac Resynchronization Therapy Study (TRUST CRT): Clinical Rationale, Design, and Implementation | Q58819423 | ||
| ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities | Q58972654 | ||
| P433 | issue | 19 | |
| P304 | page(s) | 1396-1403 | |
| P577 | publication date | 2013-01-25 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | Cardiac resynchronization therapy: state of the art 2013. | |
| P478 | volume | 34 |
| Q52375130 | Absence of Rapid Propagation through the Purkinje Network as a Potential Cause of Line Block in the Human Heart with Left Bundle Branch Block. |
| Q53427167 | Can Pulmonary Vascular Resistance Predict Response to Cardiac Resynchronization Therapy in Patients with Heart Failure? |
| Q38410468 | Cardiac resynchronisation therapy in 2015: keeping up with the pace |
| Q39037007 | Clinical Relevance Of Systematic CRT Device Optimization |
| Q85226034 | Cut-off values of myocardial perfusion gated-SPECT phase analysis parameters of normal subjects, and conduction and mechanical cardiac diseases |
| Q30392124 | Developments in Cardiac Resynchronisation Therapy |
| Q51699611 | Device therapy in cardiac disease: a success story. |
| Q44291187 | EHJ's new impact factor of 15.2: a global strategy is paying off. |
| Q47755764 | Early prediction of cardiac resynchronization therapy response by non-invasive electrocardiogram markers. |
| Q51836924 | Heart failure: the cardiovascular epidemic of the 21st century. |
| Q35827718 | Knowledge expectations, self-care, and health complaints of heart failure patients scheduled for cardiac resynchronization therapy implantation. |
| Q86839564 | Left ventricular mechanical dyssynchrony by phase analysis as a prognostic indicator in heart failure |
| Q46744044 | Long-term effectiveness of the combined minute ventilation and patient activity sensors as predictor of heart failure events in patients treated with cardiac resynchronization therapy: Results of the Clinical Evaluation of the Physiological Diagnosi |
| Q38786951 | Multi-scale, tailor-made heart simulation can predict the effect of cardiac resynchronization therapy |
| Q87973129 | Permanent His Bundle Pacing for Cardiac Resynchronization |
| Q88014373 | Prognostic Role of Right Ventricular Function in Patients With Heart Failure Undergoing Cardiac Resynchronization Therapy |
| Q42792690 | Reparative resynchronization in ischemic heart failure: an emerging strategy |
| Q89602654 | Synchronized Biventricular Heart Pacing in a Closed-chest Porcine Model based on Wirelessly Powered Leadless Pacemakers |
| Q38349753 | Therapeutic decision-making for patients with fluctuating mitral regurgitation |
| Q51627060 | Value of mechanical dyssynchrony as assessed by radionuclide ventriculography to predict the cardiac resynchronization therapy response. |
Search more.